The British journal of psychiatry : the journal of mental science
Economic evaluation of different haematological monitoring schemes for patients with treatment-resistant schizophrenia using clozapine.
Freya Diederich, Ebenezer Oloyede, David Taylor, Christian J Bachmann
Published: 202510.1192/bjp.2025.10424
Abstract
BACKGROUND: Clozapine is licensed for treatment-resistant schizophrenia (TRS). Because of the risk of clozapine-induced agranulocytosis, its use requires regular haematological monitoring. Substantive evidence supports revisions of absolute neutrophi…
Preview only. Read the full abstract at the source